Full Text View
Tabular View
No Study Results Posted
Related Studies
Plasma Citrulline Level in Relation to Absorptive Surface
This study is currently recruiting participants.
Verified by University Hospital, Ghent, April 2009
First Received: February 1, 2006   Last Updated: April 7, 2009   History of Changes
Sponsored by: University Hospital, Ghent
Information provided by: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00286039
  Purpose

Correlation between determination of citrulline in plasma or dried blood

Reference ranges for healthy children and babies

Longitudinal follow-up of citrulline in preterm babies


Condition Intervention
Intestinal "Failure"
 Procedure: Blood sampling

Drug Information available for: Citrulline
U.S. FDA Resources
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study
Official Title: Plasma Citrulline Level in Relation to Absorptive Surface

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Correlation between determination of citrulline in plasma or dried blood [ Designated as safety issue: No ]
  • Reference ranges for healthy children and babies [ Designated as safety issue: No ]
  • Longitudinal follow-up of citrulline in preterm babies [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: August 2005
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 0-18 years
  • preterm babies up to 1.500g
  • preterm babies over 1.500g

Exclusion Criteria:

  • gastro-intestinal problems (except for the preterm babies)
  • congenital metabolic disorders
  • dysfunction of the liver or kidneys
  • congenital defects
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00286039

Contacts
Contact: Linde Goossens, MD + 32 9 332.35.37 linde.goossens@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Linde Goossens, MD     +32 9 332.35.37     linde.goossens@UGent.be    
Principal Investigator: Linde Goossens, MD            
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Eddy Robberecht, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: University Hospital Ghent ( Linde Goossens )
Study ID Numbers: 2005/163
Study First Received: February 1, 2006
Last Updated: April 7, 2009
ClinicalTrials.gov Identifier: NCT00286039     History of Changes
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on May 07, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services